Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic back...
Outcomes4Me Inc., the developer of a personalized and evidence-based cancer navigation platform, and the National Comprehensive Cancer Network announced that Outcomes4Me has newly incorporated...
Genentech, a member of the Roche Group , announced positive results from the Phase II FENopta study evaluating investigational oral fenebrutinib in adults with...
With the introduction of big data analytics, the healthcare sector experienced a paradigm shift in the age of digitization. When paired with strong analytics...
Dante Genomics, a global leader in genomics and precision medicine, announced a free, initial feature of its platform agnostic proprietary B2B software to automatically...
